Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
1.
Immunohorizons ; 7(6): 412-420, 2023 06 01.
Article in English | MEDLINE | ID: mdl-37279084

ABSTRACT

Mechanisms to shorten the duration of tuberculosis (TB) treatment include new drug formulations or schedules and the development of host-directed therapies (HDTs) that better enable the host immune system to eliminate Mycobacterium tuberculosis. Previous studies have shown that pyrazinamide, a first-line antibiotic, can also modulate immune function, making it an attractive target for combinatorial HDT/antibiotic therapy, with the goal to accelerate clearance of M. tuberculosis. In this study, we assessed the value of anti-IL-10R1 as an HDT along with pyrazinamide and show that short-term anti-IL-10R1 blockade during pyrazinamide treatment enhanced the antimycobacterial efficacy of pyrazinamide, resulting in faster clearance of M. tuberculosis in mice. Furthermore, 45 d of pyrazinamide treatment in a functionally IL-10-deficient environment resulted in sterilizing clearance of M. tuberculosis. Our data suggest that short-term IL-10 blockade with standard TB drugs has the potential to improve clinical outcome by reducing the treatment duration.


Subject(s)
Mycobacterium tuberculosis , Tuberculosis , Animals , Mice , Pyrazinamide/pharmacology , Pyrazinamide/therapeutic use , Antitubercular Agents/pharmacology , Antitubercular Agents/therapeutic use , Interleukin-10
2.
Vet Pathol ; 58(5): 766-794, 2021 09.
Article in English | MEDLINE | ID: mdl-34282984

ABSTRACT

Standardization of tumor assessment lays the foundation for validation of grading systems, permits reproducibility of oncologic studies among investigators, and increases confidence in the significance of study results. Currently, there is minimal methodological standardization for assessing tumors in veterinary medicine, with few attempts to validate published protocols and grading schemes. The current article attempts to address these shortcomings by providing standard guidelines for tumor assessment parameters and protocols for evaluating specific tumor types. More detailed information is available in the Supplemental Files, the intention of which is 2-fold: publication as part of this commentary, but more importantly, these will be available as "living documents" on a website (www.vetcancerprotocols.org), which will be updated as new information is presented in the peer-reviewed literature. Our hope is that veterinary pathologists will agree that this initiative is needed, and will contribute to and utilize this information for routine diagnostic work and oncologic studies. Journal editors and reviewers can utilize checklists to ensure publications include sufficient detail and standardized methods of tumor assessment. To maintain the relevance of the guidelines and protocols, it is critical that the information is periodically updated and revised as new studies are published and validated with the intent of providing a repository of this information. Our hope is that this initiative (a continuation of efforts published in this journal in 2011) will facilitate collaboration and reproducibility between pathologists and institutions, increase case numbers, and strengthen clinical research findings, thus ensuring continued progress in veterinary oncologic pathology and improving patient care.


Subject(s)
Neoplasms , Pathology, Veterinary , Animals , Neoplasms/diagnosis , Neoplasms/veterinary , Reproducibility of Results
3.
Wound Repair Regen ; 25(3): 541-549, 2017 05.
Article in English | MEDLINE | ID: mdl-28466497

ABSTRACT

Chronic skin wounds are a significant human health concern and are often complicated by infection with Pseudomonas aeruginosa and Staphylococcus aureus, particularly methicillin resistant S. aureus (MRSA). Translating the knowledge gained from extensive study of virulence mechanisms and pathogenesis of these bacterial species to new treatment modalities has been lacking in part due to a paucity of animal models able to recapitulate human disease. Our groups recently described a novel porcine chronic burn wound model for the study of bacterial infection; however, the histopathology of infection has yet to be described. The objective of this study is to define the histopathology of this model using important human chronic wound bacterial isolates. Porcine full-thickness burn wounds topically inoculated with P. aeruginosa strain PAO1, MRSA S. aureus strain USA300 or both bacteria were used to define and quantify histopathologic lesions. The development of a systemic, well-defined rubric for analysis allowed for evaluation of differences between infection groups. These differences, which included epithelial migration and proliferation, stromal necrosis, fluid accumulation and intensity and character of the innate and adaptive inflammatory cell responses, were identified temporally between infection groups. Mono-species infected wounds developed a hyper-proliferative wound edge. Coinfected wounds at day 35 had the largest wound sizes, increased amounts of neutrophilic inflammation, immaturity of the wound bed, and retention of necrotic tissue. Infection, regardless of species, inhibited wound contracture at all time points evaluated. Most importantly, this model recapitulated key features of chronic human wounds. Thus, this model will allow researchers to study novel treatment modalities in a biologically relevant animal model while monitoring both host and bacterial responses.


Subject(s)
Burns/microbiology , Pseudomonas Infections/immunology , Staphylococcal Infections/immunology , Wound Healing/physiology , Wound Infection/microbiology , Adaptive Immunity , Animals , Burns/immunology , Cell Movement/physiology , Cell Proliferation/physiology , Disease Models, Animal , Necrosis , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/pathogenicity , Staphylococcal Infections/microbiology , Staphylococcus aureus/pathogenicity , Swine , Wound Healing/immunology , Wound Infection/pathology
6.
Am J Ther ; 23(3): e773-7, 2016.
Article in English | MEDLINE | ID: mdl-24621645

ABSTRACT

Phenytoin toxicity frequently results in a prolonged inpatient admission. Several publications avow multidose activated charcoal (MDAC) will enhance the elimination of phenytoin. However, these claims are not consistent, and the mechanism of enhanced eliminaiton is unproven. The aim of this investigation is to compare the time to reach a clinical composite end point in phenytoin overdose patients treated with no activated charcoal (NoAC), single-dose activated charcoal (SDAC), and MDAC. This was a retrospective study using electronic poison center data. Patients treated in a health care facility with phenytoin concentrations >20 mg/L were included. Patients were grouped by use of SDAC, MDAC, and NoAC. The primary end points were either time to resolution of symptoms, hospital discharge, or the case was closed by a toxicologist. After applying inclusion and exclusion criteria, 132 cases were included for analysis. There were 88 NoAC, 13 SDAC, and 31 MDAC cases. The groups were similar in symptomatology, age, and chronicity of expsoure. Mean peak phenytoin concentrations (SD) were 42 mg/L (12), 41 mg/L (11), and 42 mg/L (11) for NoAC, SDAC, and MDAC, respectively. Mean time to reach the study end point was 39 hours [95% confidence interval (CI), 31-48], 52 hours (95% CI, 36-68), and 60 hours (95% CI, 45-75) for NoAC, SDAC, and MDAC, respectively. The groups appeared similar with respect to peak phenytoin concentrations and prevalence of signs and symptoms. In this observational series, the use of activated charcoal was associated with increased time to reach the composite end point of clinical improvement.


Subject(s)
Anticonvulsants/adverse effects , Antidotes/therapeutic use , Charcoal/therapeutic use , Drug Overdose/drug therapy , Phenytoin/adverse effects , Adult , Aged , Anticonvulsants/blood , Antidotes/administration & dosage , Charcoal/administration & dosage , Drug Overdose/blood , Female , Hospitalization , Humans , Male , Middle Aged , Phenytoin/blood , Retrospective Studies , Treatment Outcome
8.
Am J Emerg Med ; 33(3): 349-51, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25592250

ABSTRACT

INTRODUCTION: Single-use laundry detergent pods (LDPs) were introduced to the United States in 2010 but had been available in Europe as early as 2001. Case reports of unintentional exposures noted vomiting, ocular injuries, respiratory depression, and central nervous system depression. We summarize clinical effects from unintentional LDP exposures reported to a single poison center over 15 months. METHODS: Electronic poison center records were searched using verbatim field and both product and generic codes to identify laundry pod exposures from January 1, 2012, through April 9, 2013. Clinical effects were abstracted to a database and summarized using descriptive statistics. RESULTS: We identified 131 cases between March 2012 and April 2013. Median (interquartile range) age was 2.0 (1.5) years with 4 adult cases; all were coded as unintentional. The most common route was ingestion (120) followed by ocular (14) and dermal (6). Some patients had multiple routes of exposure. Of ingestion exposures, 79 (66%) were managed at home; and 41 (34%) were evaluated in a hospital, of which 9 patients were admitted. The median (interquartile range) age of admitted patients was 1.4 (1.1) years. Relevant findings in these admitted children included emesis (78%), central nervous system depression (22%), upper airway effects (56%), lower respiratory symptoms (33%), seizure (n = 1), and intubation (67%). One child with emesis initially managed at home was subsequently intubated for respiratory distress. DISCUSSION: Exposure to LDP can cause significant toxicity, particularly in infants and toddlers. Compared to traditional detergents, clinicians should be aware of the potential for airway compromise following exposure to LDP.


Subject(s)
Central Nervous System Diseases/chemically induced , Detergents/poisoning , Eating , Poison Control Centers , Respiratory Distress Syndrome/chemically induced , Seizures/chemically induced , Vomiting/chemically induced , Child, Preschool , Cohort Studies , Cross-Sectional Studies , Female , Humans , Infant , Male , Respiratory Tract Diseases/chemically induced , Retrospective Studies , Virginia
10.
J Am Anim Hosp Assoc ; 50(5): 322-9, 2014.
Article in English | MEDLINE | ID: mdl-25028434

ABSTRACT

Gastrointestinal endoscopy is a minimally invasive diagnostic tool for cats and dogs with signs of gastrointestinal disease. This retrospective study examined the case records of six cats and one dog diagnosed with perforation secondary to gastrointestinal endoscopy. Gastrointestinal perforation occurred in 1.6% of cats and 0.1% of dogs that underwent endoscopy during the 17 yr study period (from 1993 to 2010). It can be difficult to predict what animals are at risk for gastrointestinal perforation but possible risk factors suggested by this study include small intestinal infiltrative disease in cats and preexisting gastrointestinal ulceration in both cats and dogs. Overall, gastrointestinal endoscopy is associated with a low rate of gastrointestinal perforation.


Subject(s)
Cat Diseases/etiology , Dog Diseases/etiology , Duodenal Diseases/veterinary , Gastroscopy/veterinary , Intestinal Perforation/veterinary , Animals , Cat Diseases/diagnosis , Cats , Dog Diseases/diagnosis , Dogs , Duodenal Diseases/etiology , Female , Gastrointestinal Diseases/diagnosis , Gastrointestinal Diseases/veterinary , Gastroscopy/adverse effects , Intestinal Perforation/etiology , Male , Peritonitis/etiology , Peritonitis/veterinary , Retrospective Studies , Treatment Outcome , Veterinary Medicine/standards
11.
J Med Toxicol ; 10(3): 254-60, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24515527

ABSTRACT

Clinicians have limited experience with assessment and treatment of overdose from newer anticonvulsant medications. The aim of this investigation was to evaluate clinical effects of newer anticonvulsant overdose, determine if a relationship exists between dose and clinical effect, and if a particular agent appears more toxic in overdose. This was a retrospective study using electronic poison center data, evaluating clinical outcomes from newer anticonvulsant overdose. The Toxicall™ database from January 1, 2002 to December 31, 2011 was queried using key words: "gabapentin," "lamotrigine," "levetiracetam," "tiagabine," "topiramate," "zonisamide," "pregabalin," and "oxcarbazine." Polypharmacy overdose and children less than 15 years of age were excluded. Charts were reviewed by two abstractors for pharmaceutical, self-reported dose, clinical effect score, and clinical signs, symptoms, and vital signs recorded in the chart. Ordinal logistic regression was used to evaluate the relationship between drug type, dose, age, and sex to clinical effect score. Out of 501 cases identified, 347 met the final inclusion criteria. There were 116 gabapentin, 67 lamotrigine, 15 levetiracetam, 15 tiagabine, 56 topiramate, 23 pregabalin, and 55 oxcarbazepine cases. Overdose of newer anticonvulsants frequently results in altered mental status. Seizures may be more common with tiagabine, lamotrigine, and oxcarbazepine. There was one death reported from intentional overdose of topiramate. An information index was created to rank drug toxicity based on reported signs and symptoms for each overdose. There was no significant effect of dose on severity of outcome (ß = 0.12, p = 0.23). However, the risk of a more severe outcome score was significantly increased with tiagabine relative to other drugs (ß = 2.8, p = 0.001). Lamotrigine ranked highest in terms of toxicity (HT = 1.66) and number of interventions performed (HI = 1.17), and levetiracetam the lowest (HT = 0.98; HI = 0.88). We could not identify a dose-effect in these data which likely reflects the limitations of self-reported doses. Despite limitations of these data, the risk of more severe outcome scores appear to be higher with tiagabine overdose while lamotrigine overdose appears to result in more reported signs, symptoms, and interventions.


Subject(s)
Anticonvulsants/poisoning , Drug Overdose , Poison Control Centers , Adolescent , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Databases, Factual , Female , Humans , Male , Middle Aged , Reproducibility of Results , Retrospective Studies
12.
PLoS One ; 8(8): e71533, 2013.
Article in English | MEDLINE | ID: mdl-23977064

ABSTRACT

Tumor fibroblasts are active partners in tumor progression, but the genes and pathways that mediate this collaboration are ill-defined. Previous work demonstrates that Ets2 function in stromal cells significantly contributes to breast tumor progression. Conditional mouse models were used to study the function of Ets2 in both mammary stromal fibroblasts and epithelial cells. Conditional inactivation of Ets2 in stromal fibroblasts in PyMT and ErbB2 driven tumors significantly reduced tumor growth, however deletion of Ets2 in epithelial cells in the PyMT model had no significant effect. Analysis of gene expression in fibroblasts revealed a tumor- and Ets2-dependent gene signature that was enriched in genes important for ECM remodeling, cell migration, and angiogenesis in both PyMT and ErbB2 driven-tumors. Consistent with these results, PyMT and ErbB2 tumors lacking Ets2 in fibroblasts had fewer functional blood vessels, and Ets2 in fibroblasts elicited changes in gene expression in tumor endothelial cells consistent with this phenotype. An in vivo angiogenesis assay revealed the ability of Ets2 in fibroblasts to promote blood vessel formation in the absence of tumor cells. Importantly, the Ets2-dependent gene expression signatures from both mouse models were able to distinguish human breast tumor stroma from normal stroma, and correlated with patient outcomes in two whole tumor breast cancer data sets. The data reveals a key function for Ets2 in tumor fibroblasts in signaling to endothelial cells to promote tumor angiogenesis. The results highlight the collaborative networks that orchestrate communication between stromal cells and tumor cells, and suggest that targeting tumor fibroblasts may be an effective strategy for developing novel anti-angiogenic therapies.


Subject(s)
Breast Neoplasms/blood supply , Breast Neoplasms/pathology , Fibroblasts/metabolism , Fibroblasts/pathology , Proto-Oncogene Protein c-ets-2/metabolism , Animals , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Carcinogenesis/genetics , Carcinogenesis/pathology , Cell Compartmentation , Disease Models, Animal , Disease Progression , Female , Gene Deletion , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Humans , Mammary Neoplasms, Animal/genetics , Mammary Neoplasms, Animal/pathology , Mice , Stromal Cells/metabolism , Stromal Cells/pathology , Treatment Outcome
14.
Clin Toxicol (Phila) ; 51(3): 182-5, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23473464

ABSTRACT

CONTEXT: Methyl bromide is a halogenated aliphatic hydrocarbon that exists as a colorless gas or a volatile liquid. Methyl bromide historically had been used in fire extinguishers but is more commonly used as a gas fumigant for soil-borne diseases and pests. Methyl bromide is being phased out due to concerns for ozone depletion but can still be found. It is readily absorbed through the lungs while dermal absorption can also occur. Signs and symptoms of severe exposures include headache, respiratory distress, pulmonary hemorrhage, and seizures. In large pulmonary exposures, death can occur as rapidly as 1 h usually from respiratory failure. Methyl bromide can penetrate clothing and protective equipment presenting challenges to first responders. There is a debate over the mechanism of toxicity of methyl bromide and the role of hemodialysis and chelation in treatment. CASE DETAILS: A 22-year-old female employee of a fumigation company contacted emergency medical services (EMS) after opening a tank of compressed methyl bromide in her car. She was initially combative and confused. She underwent two water dermal decontaminations and was transported to the nearest tertiary center. She rapidly progressed to obtundation with seizure-like activity and dysrhythmias. Despite the supportive care and resuscitative efforts, she died approximately 1 h after her call to EMS. DISCUSSION: Methyl bromide exposures can be fatal, and this case highlights the difficulty in managing these acutely poisoned patients. Questions for consideration after this case include time spent on decontamination, use of adjunctive anti-epileptic drugs, role of chelation therapy, and the role of hemodialysis in the treatment of methyl bromide poisoning.


Subject(s)
Confusion/chemically induced , Exanthema/chemically induced , Fumigation/adverse effects , Hydrocarbons, Brominated/poisoning , Occupational Diseases/chemically induced , Seizures/chemically induced , Critical Care/methods , Female , Humans , Young Adult
15.
J Immunol ; 190(6): 2778-90, 2013 Mar 15.
Article in English | MEDLINE | ID: mdl-23396944

ABSTRACT

Protective immunity and latent Mycobacterium tuberculosis infection in humans are associated with the formation of mature protective granulomas within the lung. Unfortunately, understanding the importance of such structures has been hindered by the lack of small-animal models that can develop mature granulomas. In this article, we describe for the first time, to our knowledge, the formation of mature, fibrotic M. tuberculosis-containing pulmonary granulomas in a mouse model of IL-10 deficiency (CBA/J IL-10(-/-)). Long-term control of M. tuberculosis infection in the absence of IL-10 was also associated with an early and enhanced capacity for Ag presentation and a significant increase in the generation of multifunctional T cells. Although IL-10 deficiency is known to enhance Th1 immune responses in general, we demonstrate in this study using transient anti-IL-10R treatment that it is the presence of IL-10 in vivo during the first month of M. tuberculosis infection that plays a definitive role in the inhibition of optimum protective immunity that can establish the environment for mature granuloma formation. Although the importance of IL-10 during M. tuberculosis infection has been debated, our data demonstrate that in CBA/J mice, IL-10 plays a significant early inhibitory role in preventing the development of protective immunity associated with containment of M. tuberculosis infection.


Subject(s)
Granuloma, Respiratory Tract/immunology , Granuloma, Respiratory Tract/prevention & control , Interleukin-10/physiology , Mycobacterium tuberculosis/immunology , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/prevention & control , Animals , Bacterial Load , Disease Models, Animal , Fibrosis/prevention & control , Granuloma, Respiratory Tract/microbiology , Interleukin-10/deficiency , Interleukin-10/genetics , Lung/immunology , Lung/microbiology , Lung/pathology , Lymph Nodes/immunology , Lymph Nodes/microbiology , Lymph Nodes/pathology , Mice , Mice, Inbred C3H , Mice, Inbred CBA , Mice, Knockout , Spleen/immunology , Spleen/microbiology , Spleen/pathology , Tuberculosis, Pulmonary/microbiology
16.
Infect Immun ; 81(4): 1090-9, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23340310

ABSTRACT

The expression of T cell differentiation markers is known to increase during Mycobacterium tuberculosis infection, and yet the biological role of such markers remains unclear. We examined the requirement of the T cell differentiation marker killer cell lectin-like receptor G1 (KLRG1) during M. tuberculosis infection using mice deficient in KLRG1. KLRG1(-/-) mice had a significant survival extension after M. tuberculosis infection compared to wild-type controls, and maintained a significantly lower level of pulmonary M. tuberculosis throughout chronic infection. Improved control of M. tuberculosis infection was associated with an increased number of activated pulmonary CD4(+) T cells capable of secreting gamma interferon (IFN-γ). Our report is the first to show an in vivo impact of KLRG1 on disease control.


Subject(s)
Mycobacterium tuberculosis/pathogenicity , Receptors, Immunologic/metabolism , Tuberculosis/pathology , Animals , Bacterial Load , CD4-Positive T-Lymphocytes/immunology , Interferon-gamma/metabolism , Lectins, C-Type , Lung/microbiology , Lung/pathology , Mice , Mice, Knockout , Mycobacterium tuberculosis/immunology , Receptors, Immunologic/deficiency , Survival Analysis , Tuberculosis/immunology , Tuberculosis/mortality
17.
J Vet Diagn Invest ; 24(6): 1073-82, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22977112

ABSTRACT

Clinical information supplied to diagnostic laboratories through biopsy submission forms is crucial to accurate, timely diagnosis and to clinicopathologic correlation between microscopic findings and the clinical condition of the patient. The current study attempts to quantify the prevalence of deficient and inadequate submissions in veterinary biopsy service and to determine whether form characteristics, such as the open or closed nature of the form and the presence of specific prompts, influence reporting of essential case information. The hypotheses of this study are, first, that deficient and inadequate biopsy submissions do occur in veterinary medicine and, second, that open-type biopsy submission forms elicit quantitatively and qualitatively more complete case information overall, and in specific content areas, compared to closed-type biopsy submission forms. Three percent of submissions reviewed were information deficient, devoid of information beyond patient signalment, and more than 88% of forms supplied inadequate clinical information in at least 1 key content area. Both form type and specific prompts significantly influenced reporting of important clinical information. This study demonstrates the need and lays the foundation for informational completeness research in veterinary medicine.


Subject(s)
Biopsy/veterinary , Laboratories/standards , Pathology, Surgical/standards , Records/veterinary , Veterinary Medicine/standards , Animals , Biopsy/standards , Practice Guidelines as Topic , Specimen Handling
18.
Eur J Immunol ; 42(4): 870-9, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22531914

ABSTRACT

In CBA/J mice, susceptibility to Mycobacterium tuberculosis (M.tb) is associated with low interferon-gamma (IFN-γ) responses to antigens (Antigen 85 (Ag85) and early secreted antigenic target-6 (ESAT-6)) that have been defined as immunodominant. Here, we asked whether the failure of CBA/J mice to recognize Ag85 is a consequence of M.tb infection or whether CBA/J mice have a general defect in generating specific T-cell responses to this protein antigen. We compared CBA/J mice during primary M.tb infection, Ag85 vaccination followed by M.tb challenge, or M.tb memory immune mice for their capacity to generate Ag85-specific IFN-γ responses and to control M.tb infection. CBA/J mice did not respond efficiently to Ag85 in the context of natural infection or re-infection. In contrast, CBA/J mice could generate Ag85-specific IFN-γ responses and protective immunity when this antigen was delivered as a soluble protein. Our data indicate that although M.tb infection of CBA/J mice does not drive an Ag85 response, these mice can fully and protectively respond to Ag85 if it is delivered as a vaccine. The data from this experimental model suggest that the Ag85-containing vaccines in clinical trials should protect M.tb susceptible humans.


Subject(s)
Antigens, Bacterial/pharmacology , Immunologic Memory/drug effects , Mycobacterium tuberculosis/immunology , T-Lymphocytes/immunology , Tuberculosis/immunology , Tuberculosis/prevention & control , Animals , Antigens, Bacterial/immunology , Disease Models, Animal , Humans , Interferon-gamma/immunology , Mice , Vaccination
19.
Clin Toxicol (Phila) ; 50(3): 221-2, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22372792

ABSTRACT

A 20-year-old woman presented to the emergency department for evaluation of a wound to left hand (Fig. 1). She admitted having a history of chronic severe headaches requiring daily use of analgesics. She first noted the ulcer approximately 10 months prior to presentation. Her examination was remarkable for a 10-cm by 8-cm ulceration to the dorsum of her left hand with exposed and necrotic metacarpals. Fibrous exudate was present in the wound-bed, and the ulcer was associated with a foul odor. She was afebrile on presentation with a peripheral white blood cell count of 6.4 x109/L, CRP 1.9 mg/dL, and ESR 15 mm/h.


Subject(s)
Analgesics, Opioid/poisoning , Pentazocine/poisoning , Skin Ulcer/chemically induced , Substance-Related Disorders , Amputation, Surgical , Analgesics, Opioid/administration & dosage , Chronic Disease , Drug Overdose , Female , Hand/pathology , Hand/surgery , Humans , Injections, Intravenous , Necrosis/chemically induced , Necrosis/pathology , Osteomyelitis/chemically induced , Osteomyelitis/pathology , Osteomyelitis/therapy , Pentazocine/administration & dosage , Skin Ulcer/pathology , Skin Ulcer/therapy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...